While WT1 was originally identified as a tumor suppressor of kidney cancer, its critical role in AML development in transgenic mice transduced with AML1-ETO [46], resistance to death stimuli [47], and importance as a prognostic marker of patient relapse and survival [48] demonstrate its functions as an oncogene in AML. Here, WT1 is linked to acute myeloid leukemia.